About the Author
Krishna Sravya
Regulatory Affairs Specialist (M.Pharm) at PharmaKnowl, focused on SFDA compliance and intelligence for Pharma and MedTech.
Mohammed Jobran Delivers Keynote on Market Entry Strategies and Compliance Pathways for Global Life Sciences Companies
PharmaKnowl Consulting is pleased to share that our Founder and Principal Consultant, Mohammed Jobran, was invited as a keynote speaker at the 2025 International High-End Pharmaceutical Forum, a pre-CPHI China event organized by Kexing Biopharm. The forum brought together regulatory authorities, industry leaders, and innovation-driven companies.
In his presentation, Mr. Jobran provided strategic insights into Saudi Arabia’s evolving regulatory landscape, focusing on opportunities for biotech, pharmaceutical, and medical technology (MedTech) companies seeking market entry into the Kingdom.
“Saudi Arabia is not just a market; it’s a strategic growth platform for global life sciences. Our mission is to make that entry smoother, faster, and fully compliant,” he stated.
Drawing from his tenure as a former SFDA, Mr. Jobran outlined the critical importance of early regulatory planning, compliance alignment, and strong local partnerships, core areas in which PharmaKnowl delivers tailored support to international clients.
The session attracted strong interest from Chinese and international attendees, particularly around SFDA registration pathways, pharmacovigilance requirements, and clinical trial opportunities in Saudi Arabia.
PharmaKnowl remains committed to supporting life science innovators worldwide in navigating Saudi Arabia’s regulatory landscape with confidence and clarity.
About the Author
Krishna Sravya
Regulatory Affairs Specialist (M.Pharm) at PharmaKnowl, focused on SFDA compliance and intelligence for Pharma and MedTech.
Resources
Services
Events
